{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:27:40Z","timestamp":1790288860644,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA021525"],"award-info":[{"award-number":["U01DA021525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Widespread health service disruptions resulting from the COVID-19 pandemic coincided with a dramatic increase in overdose deaths among people who use drugs (PWUD) in Vancouver, Canada. Those with a history of injection drug use are known to be at heightened risk of substance-associated harms. Drug use patterns and associated sociodemographic and health care utilization trends have been understudied in this population since the pandemic onset. We sought to understand patterns of drug use initiation and\/or re-initiation among people with a history of injection drug use (IVDU).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data were obtained from three harmonized prospective cohort studies of PWUD in Vancouver. Participants with a lifetime history of IVDU who responded to a survey between June 2021 and May 2022 were included. The primary outcome variable was a composite of substance use initiation and re-initiation over the study period, labelled as drug (re)-initiation. A multivariable generalized linear mixed-effects model was used to examine factors associated with self-reported (re)-initiation of substance use over the past six months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 1061 participants, the median age was 47 years at baseline and 589 (55.5%) identified as men. In total, 183 (17.2%) participants reported initiating and\/or re-initiating a drug, with 44 (4.1%) reporting new drug initiation and 148 (14.0%) reporting drug re-initiation (9 participants responded \u2018yes\u2019 to both). Overall, unregulated stimulants (e.g., crystal methamphetamine and cocaine) were the most common drug class (re-)initiated (n\u2009=\u2009101; 55.2%), followed by opioids (n\u2009=\u200974; 40.4%) and psychedelics (n\u2009=\u200936; 19.7%). In the multivariable analysis, (re-)initiation of drug use was independently associated with recent IVDU (adjusted odds ratio [AOR] 2.62, 95% confidence interval [CI] 1.02, 6.76), incarceration (AOR 3.36, CI 1.12, 10.14) and inability to access addiction treatment (AOR 4.91, 95% CI 1.22, 19.75).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In an era impacted by the intersecting effects of the COVID-19 pandemic and the overdose crisis, nearly one in five PWUD with a history of IVDU began using a new drug and\/or re-started use of a previous drug. Those who reported drug (re-)initiation exhibited riskier substance use behaviours and reported difficulty accessing treatment services. Our findings underscore the need to provide additional resources to support this high-risk population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13011-024-00624-8","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T09:04:01Z","timestamp":1725959041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Initiation and\/or re-initiation of drug use among people who use drugs in Vancouver, Canada from 2021 to 2022: a prospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Anjali","family":"Sergeant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-J","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"issue":"1","key":"624_CR1","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1016\/S2468-2667(21)00235-8","volume":"7","author":"GC Barron","year":"2022","unstructured":"Barron GC, Laryea-Adjei G, Vike-Freiberga V, et al. Safeguarding people living in vulnerable conditions in the COVID-19 era through universal health coverage and social protection. Lancet Public Health Jan. 2022;7(1):e86\u201392. https:\/\/doi.org\/10.1016\/S2468-2667(21)00235-8.","journal-title":"Lancet Public Health Jan"},{"key":"624_CR2","doi-asserted-by":"publisher","first-page":"108177","DOI":"10.1016\/j.jsat.2020.108177","volume":"121","author":"SM Murphy","year":"2021","unstructured":"Murphy SM, Yoder J, Pathak J, Avery J. Healthcare utilization patterns among persons who use drugs during the COVID-19 pandemic. J Subst Abuse Treat Feb. 2021;121:108177. https:\/\/doi.org\/10.1016\/j.jsat.2020.108177.","journal-title":"J Subst Abuse Treat Feb"},{"key":"624_CR3","doi-asserted-by":"publisher","first-page":"108617","DOI":"10.1016\/j.drugalcdep.2021.108617","volume":"01","author":"BP Jacka","year":"2021","unstructured":"Jacka BP, Janssen T, Garner BR, et al. Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder. Drug Alcohol Depend Apr. 2021;01:221:108617. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108617.","journal-title":"Drug Alcohol Depend Apr"},{"issue":"4","key":"624_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/YCO.0000000000000722","volume":"01","author":"CW Striley","year":"2021","unstructured":"Striley CW, Hoeflich CC. Converging public health crises: substance use during the coronavirus disease 2019 pandemic. Curr Opin Psychiatry Jul. 2021;01(4):325\u201331. https:\/\/doi.org\/10.1097\/YCO.0000000000000722.","journal-title":"Curr Opin Psychiatry Jul"},{"issue":"4","key":"624_CR5","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/dar.13424","volume":"41","author":"H Palis","year":"2022","unstructured":"Palis H, B\u00e9lair MA, Hu K, Tu A, Buxton J, Slaunwhite A. Overdose deaths and the COVID - 19 pandemic in British Columbia, Canada. Drug Alcohol Rev. 2022;41(4):912\u20137.","journal-title":"Drug Alcohol Rev"},{"key":"624_CR6","unstructured":"Illicit Drug Toxicity Deaths in BC: January 1. 2012 \u2013 December 31, 2022. Ministry of Public Safety & Solicitor General. Accessed May 5, 2023. https:\/\/www2.gov.bc.ca\/assets\/gov\/birth-adoption-death-marriage-and-divorce\/deaths\/coroners-service\/statistical\/illicit-drug.pdf"},{"issue":"1","key":"624_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-016-0053-6","volume":"11","author":"A Prangnell","year":"2016","unstructured":"Prangnell A, Daly-Grafstein B, Dong H, et al. Factors associated with inability to access addiction treatment among people who inject drugs in Vancouver, Canada. Subst Abuse Treat Prev Policy. 2016;11(1):1\u20138.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"12","key":"624_CR8","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1111\/add.14756","volume":"114","author":"H Dong","year":"2019","unstructured":"Dong H, Hayashi K, Singer J, et al. Trajectories of injection drug use among people who use drugs in Vancouver, Canada, 1996\u20132017: growth mixture modeling using data from prospective cohort studies. Addict Dec. 2019;114(12):2173\u201386. https:\/\/doi.org\/10.1111\/add.14756.","journal-title":"Addict Dec"},{"issue":"8","key":"624_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00002030-199708000-00001","volume":"11","author":"SA Strathdee","year":"1997","unstructured":"Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):59\u201365.","journal-title":"AIDS"},{"key":"624_CR10","doi-asserted-by":"crossref","unstructured":"Wood E, Stoltz J-A, Montaner JS, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J. 2006;3(18).","DOI":"10.1186\/1477-7517-3-18"},{"issue":"2","key":"624_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","volume":"110","author":"TJ Cicero","year":"2020","unstructured":"Cicero TJ, Ellis MS, Kasper ZA. Polysubstance use: a broader understanding of substance use during the opioid crisis. Am J Public Health. 2020;110(2):244\u201350.","journal-title":"Am J Public Health"},{"issue":"6","key":"624_CR12","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/dar.13690","volume":"42","author":"M Karamouzian","year":"2023","unstructured":"Karamouzian M, Cui Z, Hayashi K, et al. Longitudinal latent polysubstance use patterns among a cohort of people who use opioids in Vancouver, Canada. Drug Alcohol Rev Sep. 2023;42(6):1493\u2013503. https:\/\/doi.org\/10.1111\/dar.13690.","journal-title":"Drug Alcohol Rev Sep"},{"key":"624_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11524-012-9771-x","volume":"90","author":"IA Linden","year":"2013","unstructured":"Linden IA, Mar M, Werker GR, Jang K, Krausz M. Research on a vulnerable neighborhood\u2014the Vancouver Downtown Eastside from 2001 to 2011. J Urb Health. 2013;90:559\u201373.","journal-title":"J Urb Health"},{"key":"624_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugalcdep.2016.08.631","volume":"01","author":"L Wang","year":"2016","unstructured":"Wang L, Panagiotoglou D, Min JE, et al. Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting. Drug Alcohol Depend Nov. 2016;01:168:22\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.08.631.","journal-title":"Drug Alcohol Depend Nov"},{"key":"624_CR15","doi-asserted-by":"publisher","first-page":"109624","DOI":"10.1016\/j.drugalcdep.2022.109624","volume":"01","author":"Z Cui","year":"2022","unstructured":"Cui Z, Hayashi K, Bach P, Dong H, Milloy MJ, Kerr T. Predictors of crystal methamphetamine use initiation or re-initiation among people receiving opioid agonist therapy: a prospective cohort study. Drug Alcohol Depend Nov. 2022;01:240:109624. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109624.","journal-title":"Drug Alcohol Depend Nov"},{"issue":"1","key":"624_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/pubmed\/fdx187","volume":"01","author":"W Damon","year":"2019","unstructured":"Damon W, McNeil R, Milloy MJ, Nosova E, Kerr T, Hayashi K. Residential eviction predicts initiation of or relapse into crystal methamphetamine use among people who inject drugs: a prospective cohort study. J Public Health (Oxf) Mar. 2019;01(1):36\u201345. https:\/\/doi.org\/10.1093\/pubmed\/fdx187.","journal-title":"J Public Health (Oxf) Mar"},{"key":"624_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2017.10.020","volume":"183","author":"K Hayashi","year":"2017","unstructured":"Hayashi K, Milloy M-J, Lysyshyn M, et al. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: a cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2017;183:1\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"624_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"01","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry Jul. 2021;01(4):344\u201350. https:\/\/doi.org\/10.1097\/YCO.0000000000000717.","journal-title":"Curr Opin Psychiatry Jul"},{"issue":"1","key":"624_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12954-022-00607-7","volume":"04","author":"J Can\u00eado","year":"2022","unstructured":"Can\u00eado J, Sedgemore KO, Ebbert K, et al. Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon. Harm Reduct J May. 2022;04(1):43. https:\/\/doi.org\/10.1186\/s12954-022-00607-7.","journal-title":"Harm Reduct J May"},{"key":"624_CR20","doi-asserted-by":"crossref","unstructured":"Ronsley C, Nolan S, Knight R et al. Treatment of stimulant use disorder: a systematic review of reviews. PLoS ONE. 2020;15(6).","DOI":"10.1371\/journal.pone.0234809"},{"issue":"49","key":"624_CR21","doi-asserted-by":"publisher","first-page":"E1695","DOI":"10.1503\/cmaj.1096029","volume":"19","author":"K Zannese","year":"2022","unstructured":"Zannese K. High time? Psychedelics on cannabis-like fast track to legalization. CMAJ Dec. 2022;19(49):E1695\u20136. https:\/\/doi.org\/10.1503\/cmaj.1096029.","journal-title":"CMAJ Dec"},{"issue":"7","key":"624_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/cap.2019.0013","volume":"29","author":"R Lyons","year":"2019","unstructured":"Lyons R, Yule A, Schiff D, Bagley S, Wilens T. Risk factors for drug overdose in young people: a systematic review of the literature. J Child Adolesc Psychopharmacol. 2019;29(7):487\u201397.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"624_CR23","doi-asserted-by":"publisher","first-page":"109714","DOI":"10.1016\/j.drugalcdep.2022.109714","volume":"01","author":"M Cano","year":"2023","unstructured":"Cano M, Oh S, Osborn P, et al. County-level predictors of US drug overdose mortality: a systematic review. Drug Alcohol Depend Jan. 2023;01:242:109714. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109714.","journal-title":"Drug Alcohol Depend Jan"},{"issue":"6","key":"624_CR24","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/add.15293","volume":"116","author":"WQ Gan","year":"2021","unstructured":"Gan WQ, Kinner SA, Nicholls TL, et al. Risk of overdose-related death for people with a history of incarceration. Addict Jun. 2021;116(6):1460\u201371. https:\/\/doi.org\/10.1111\/add.15293.","journal-title":"Addict Jun"},{"key":"624_CR25","doi-asserted-by":"publisher","first-page":"103236","DOI":"10.1016\/j.drugpo.2021.103236","volume":"93","author":"T Nguyen","year":"2021","unstructured":"Nguyen T, Buxton JA. Pathways between COVID-19 public health responses and increasing overdose risks: a rapid review and conceptual framework. Int J Drug Policy Jul. 2021;93:103236. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103236.","journal-title":"Int J Drug Policy Jul"},{"key":"624_CR26","doi-asserted-by":"crossref","unstructured":"Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): a national qualitative study. J Subst Abuse Treat. 2021;129.","DOI":"10.1016\/j.jsat.2021.108374"},{"key":"624_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugpo.2015.08.007","volume":"27","author":"B Fischer","year":"2016","unstructured":"Fischer B, Murphy Y, Rudzinski K, MacPherson D. Illicit drug use and harms, and related interventions and policy in Canada: a narrative review of select key indicators and developments since 2000. Int J Drug Policy. 2016;27:23\u201335.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"624_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12954-024-00996-x","volume":"16","author":"S Mitra","year":"2024","unstructured":"Mitra S, Bouck Z, Larney S, et al. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis. Harm Reduct J May. 2024;16(1):94. https:\/\/doi.org\/10.1186\/s12954-024-00996-x.","journal-title":"Harm Reduct J May"},{"issue":"2","key":"624_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.drugpo.2005.12.007","volume":"17","author":"E Wood","year":"2006","unstructured":"Wood E, Kerr T. What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. Int J Drug Policy. 2006;17(2):55\u201360.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"624_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/dar.12427","volume":"36","author":"E Hyshka","year":"2017","unstructured":"Hyshka E, Anderson JT, Wild TC. Perceived unmet need and barriers to care amongst street-involved people who use illicit drugs. Drug Alcohol Rev May. 2017;36(3):295\u2013304. https:\/\/doi.org\/10.1111\/dar.12427.","journal-title":"Drug Alcohol Rev May"},{"issue":"1","key":"624_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13722-021-00275-1","volume":"13","author":"N Krawczyk","year":"2021","unstructured":"Krawczyk N, Fawole A, Yang J, Tofighi B. Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review. Addict Sci Clin Pract Nov. 2021;13(1):68. https:\/\/doi.org\/10.1186\/s13722-021-00275-1.","journal-title":"Addict Sci Clin Pract Nov"},{"key":"624_CR32","doi-asserted-by":"publisher","first-page":"108153","DOI":"10.1016\/j.jsat.2020.108153","volume":"119","author":"L MacKinnon","year":"2020","unstructured":"MacKinnon L, Soc\u00edas ME, Bardwell G. COVID-19 and overdose prevention: challenges and opportunities for clinical practice in housing settings. J Subst Abuse Treat Dec. 2020;119:108153. https:\/\/doi.org\/10.1016\/j.jsat.2020.108153.","journal-title":"J Subst Abuse Treat Dec"},{"key":"624_CR33","doi-asserted-by":"publisher","first-page":"103237","DOI":"10.1016\/j.drugpo.2021.103237","volume":"93","author":"F Ali","year":"2021","unstructured":"Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy Jul. 2021;93:103237. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103237.","journal-title":"Int J Drug Policy Jul"},{"issue":"9738","key":"624_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","volume":"31","author":"FL Altice","year":"2010","unstructured":"Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet Jul. 2010;31(9738):367\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(10)60829-X.","journal-title":"Lancet Jul"},{"key":"624_CR35","doi-asserted-by":"publisher","first-page":"116920","DOI":"10.1016\/j.socscimed.2024.116920","volume":"350","author":"LL Munasinghe","year":"2024","unstructured":"Munasinghe LL, Yin W, Nathani H, et al. The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: are we ready for the next pandemic? Soc Sci Med Jun. 2024;350:116920. https:\/\/doi.org\/10.1016\/j.socscimed.2024.116920.","journal-title":"Soc Sci Med Jun"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-024-00624-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-024-00624-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-024-00624-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T21:04:14Z","timestamp":1726002254000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-024-00624-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1186\/s13011-024-00624-8","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for each cohort was obtained from the University of British Columbia\/Providence Health Care Research Ethics Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KH holds the St. Paul\u2019s Hospital Chair in Substance Use Research and is supported in part by the NIH (U01DA038886) and the St. Paul\u2019s Foundation. PB is supported by a Health Professional-Investigator Award from Michael Smith Health Research BC, the St. Paul\u2019s Foundation, and the BC Centre on Substance Use. MM holds the Canopy Growth professorship in cannabis science at UBC, a position created by arms\u2019 length gifts to the university from Canopy Growth, a licenced producer of cannabis, and the Government of British Columbia\u2019s Ministry of Mental Health and Addiction.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}